Peter Lee
Investing Profile
Sweet spot: $1.5M
Range: $100K–$5M
AVANT BIO thesis
Our Approach A laser focus on the enabling technologies shaping how tomorrow’s therapeutics are developed. We Are Focused We See New Opportunities We Catalyze Value We Are Focused AVANT BIO is dedicated to fueling innovative companies in the Life Sciences and Healthtech space that are developing Therapeutic-Enabling Technologies capable of making therapies more accessible and unlocking new possibilities. Thematic Focus Equitable Access to Therapies Globally Speed and Quality in Drug Discovery New Modalities, New Needs Robust, Reliable manufacturing & Supply Chain Clinical Trial Access, Diversi
Sector and stage focus
- Series A: Consumer Health, Health IT, BioTech, Health & Hospital Services, Digital Health
- Seed: BioTech, Consumer Health, Health IT, Digital Health, Health & Hospital Services
- general: New York City
Is Peter Lee a fit for your round?
Upload your pitch deck and see whether Peter Lee appears in your top 20 matches.
Find investors for your deck